Dr. Michael Miedema

Jon DeHaan is pleased to personally award Dr. Michael Miedema's research into the prognostic significance and clinical utility of coronary artery calcium (CAC) for risk assessment for atherosclerotic cardiovascular disease (ASCVD) in younger adults.

​

Dr. Michael Miedema is the director of cardiovascular prevention at the Minneapolis Heart Institute and the medical director of the Nolan Family Center for Cardiovascular Health at the Minneapolis Heart Institute Foundation. He attended medical school at the University of Minnesota, completed internal medicine residency at Abbott Northwestern Hospital in Minneapolis, and then returned to the University of Minnesota to complete his cardiovascular fellowship. He completed his training in Boston, Massachusetts with a cardiovascular prevention fellowship at Brigham and Women’s Hospital as well as obtaining a master’s in public health from Harvard University School of Public Health. He started his position with the Minneapolis Heart Institute in 2013 and is focusing his research on determining the optimal individual and population based approaches for the prevention of cardiovascular disease. Dr. Miedema was a member of the executive review committee for the 2018 ACC/AHA cholesterol guidelines, was a committee member for the 2019 ACC/AHA guidelines for the primary prevention of cardiovascular disease, and is a current member of the American Heart Association Diabetes Council.

​

Says Dr. Miedema, "I am very honored to receive this award from the Jon DeHaan Center for Medical Innovation. At the Nolan Family Center for Cardiovascular Health at the Minneapolis Heart Institute Foundation, we are trying to improve cardiovascular health through research, education, and leadership and this award provides validation of those efforts. It is greatly appreciated."

​

Read Dr. Miedema's publication, "Coronary Artery Calcium for Risk Assessment in Young Adults" here.